| __timestamp | Amgen Inc. | Taro Pharmaceutical Industries Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 4297000000 | 55430000 |
| Thursday, January 1, 2015 | 4070000000 | 65510000 |
| Friday, January 1, 2016 | 3840000000 | 71160000 |
| Sunday, January 1, 2017 | 3562000000 | 70644000 |
| Monday, January 1, 2018 | 3737000000 | 70418000 |
| Tuesday, January 1, 2019 | 4116000000 | 63238000 |
| Wednesday, January 1, 2020 | 4207000000 | 59777000 |
| Friday, January 1, 2021 | 4819000000 | 60152000 |
| Saturday, January 1, 2022 | 4434000000 | 54540000 |
| Sunday, January 1, 2023 | 4784000000 | 52243000 |
| Monday, January 1, 2024 | 5964000000 | 64536000 |
Unleashing the power of data
In the competitive world of pharmaceuticals, research and development (R&D) spending is a key indicator of innovation and future growth. Over the past decade, Amgen Inc. and Taro Pharmaceutical Industries Ltd. have shown contrasting approaches to R&D investment. From 2014 to 2023, Amgen consistently allocated a significant portion of its resources to R&D, with expenditures peaking at approximately $4.8 billion in 2021. This represents a steady increase of around 35% from its 2017 low. In contrast, Taro's R&D spending remained relatively stable, averaging around $63 million annually, with a slight dip in 2022. This disparity highlights Amgen's aggressive pursuit of innovation compared to Taro's more conservative strategy. As we look to the future, the missing data for 2024 leaves us curious about how these companies will adapt their strategies in an ever-evolving industry.
Who Prioritizes Innovation? R&D Spending Compared for Eli Lilly and Company and Taro Pharmaceutical Industries Ltd.
R&D Insights: How Novo Nordisk A/S and Taro Pharmaceutical Industries Ltd. Allocate Funds
R&D Insights: How Johnson & Johnson and Amgen Inc. Allocate Funds
Analyzing R&D Budgets: Novartis AG vs Amgen Inc.
Research and Development: Comparing Key Metrics for Amgen Inc. and Intra-Cellular Therapies, Inc.
Comparing Innovation Spending: Amgen Inc. and Opthea Limited
R&D Insights: How Amgen Inc. and CRISPR Therapeutics AG Allocate Funds
Research and Development Investment: Amgen Inc. vs Celldex Therapeutics, Inc.
Amgen Inc. or Travere Therapeutics, Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: Vertex Pharmaceuticals Incorporated and Taro Pharmaceutical Industries Ltd.
Takeda Pharmaceutical Company Limited or Taro Pharmaceutical Industries Ltd.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Summit Therapeutics Inc. and Taro Pharmaceutical Industries Ltd.